What is X-trodes?
X-trodes is pioneering the field of bio-convergence with its innovative Smart Skin technology. This wearable solution is designed for advanced electrophysiological monitoring, allowing patients to be monitored in their natural environments. The technology aims to provide detailed analytics, potentially transforming remote patient care and medical research by offering a non-invasive and continuous data stream.
How much funding has X-trodes raised?
X-trodes has raised a total of $4.5M across 1 funding round:
Angel/Seed
$4.5M
Angel/Seed (2021): $4.5M with participation from Japan Israel High Tech Ventures, Jeremy Coller, and Welltech
Key Investors in X-trodes
Japan Israel High Tech Ventures
Japan Israel High Tech Ventures is an investment firm focused on fostering technological collaboration and innovation between Japan and Israel. They typically back companies with disruptive technologies and strong market potential.
Jeremy Coller
Jeremy Coller is a notable investor known for his involvement in various technology and impact-focused ventures. His backing suggests a belief in X-trodes' potential for both technological advancement and positive societal impact.
Welltech
Welltech, a creative solutions company specializing in brand development, digital transformation, and app development, likely provides strategic support and digital expertise to its portfolio companies, aiding in market positioning and user engagement.
What's next for X-trodes?
The recent major strategic investment signals a pivotal growth phase for X-trodes. This capital infusion is expected to accelerate the company's product development, scale manufacturing capabilities, and expand its market reach. The focus on enterprise-level funding suggests a strategic alignment with larger healthcare or technology partners, positioning X-trodes for significant market penetration and the establishment of its Smart Skin technology as a new standard in wearable health monitoring.
See full X-trodes company page
